Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jenny Kim, Ellen Sidransky & Grisel Lopez. (2015) Understanding and managing parkinsonism in patients with glucocerebrosidase mutations. Expert Opinion on Orphan Drugs 3:5, pages 549-562.
Read now
Read now
Catherine M. Bollard. (2014) A Change in the Editorial Office: Farewell from Catherine M. Bollard. Pediatric Hematology and Oncology 31:5, pages 393-394.
Read now
Read now
Sawa Ito & A. John Barrett. (2013) Response to the Letter: Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease. Pediatric Hematology and Oncology 30:5, pages 462-463.
Read now
Read now
Maciej Machaczka. (2013) Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease. Pediatric Hematology and Oncology 30:5, pages 459-461.
Read now
Read now
Articles from other publishers (19)
Raphael Schiffmann, Timothy M Cox, Jean-François Dedieu, Sebastiaan J M Gaemers, Julia B Hennermann, Hiroyuki Ida, Eugen Mengel, Pascal Minini, Pramod Mistry, Petra B Musholt, David Scott, Jyoti Sharma & M Judith Peterschmitt. (2023) Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial. Brain 146:2, pages 461-474.
Crossref
Crossref
Weijing Kong, Cheng Lu, Yingxue Ding & Yan Meng. (2022) Update of treatment for Gaucher disease. European Journal of Pharmacology 926, pages 175023.
Crossref
Crossref
Panagiota Tsitsi, Ioanna Markaki, Josefine Waldthaler, Maciej Machaczka & Per Svenningsson. (2021) Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease. JIMD Reports 63:1, pages 93-100.
Crossref
Crossref
Danijela Petković Ramadža, Marija Zekušić, Tamara Žigman, Ana Škaričić, Ana Bogdanić, Gordana Mustać, Katarina Bošnjak-Nađ, David Ozretić, Kousaku Ohno, Ksenija Fumić & Ivo Barić. (2021) Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings. European Journal of Paediatric Neurology 32, pages 66-72.
Crossref
Crossref
Angela Sun, Irene J. Chang, Christina Lam & Gerard T. Berry. 2021. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
563
682
.
Kleebsabai Sanpakit, Nattee Narkbunnam, Jassada Buaboonnam, Chayamon Takpradit, Vip Viprakasit & Bunchoo Pongtanakul. (2020) Impact of splenectomy on outcomes of hematopoietic stem cell transplantation in pediatric patients with transfusion‐dependent thalassemia. Pediatric Blood & Cancer 67:9.
Crossref
Crossref
Samantha G. Scharenberg, Edina Poletto, Katherine L. Lucot, Pasqualina Colella, Adam Sheikali, Thomas J. Montine, Matthew H. Porteus & Natalia Gomez-Ospina. (2020) Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing. Nature Communications 11:1.
Crossref
Crossref
Eun Ah Kim, Young Tae Lim, Jeong Ok Hah, Young Bae Sohn, Yu Kyung Kim, Joon Hyuk Choi, Sae Yoon Kim, Kyung Mi Jang, JiYoung Ahn & Jae Min Lee. (2018) Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia. International Journal of Hematology 109:3, pages 361-365.
Crossref
Crossref
Sichen DuHuayuan OuRenjie CuiNan JiangMeiqin ZhangXiaorong LiJing MaJin ZhangDuan Ma. (2019) Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease. Human Gene Therapy 30:2, pages 155-167.
Crossref
Crossref
Joshua L. Bonkowsky, Jacob Wilkes & David C. Shyr. (2018) Scope and Burden of Non–Standard of Care Hematopoietic Stem Cell Transplantation in Pediatric Leukodystrophy Patients. Journal of Child Neurology 33:14, pages 882-887.
Crossref
Crossref
Michael J. Gambello & Hong Li. (2018) Current strategies for the treatment of inborn errors of metabolism. Journal of Genetics and Genomics 45:2, pages 61-70.
Crossref
Crossref
Ratna Dua Puri, Seema Kapoor, Priya S. Kishnani, Ashwin Dalal, Neerja Gupta, Mamta Muranjan, Shubha R. Phadke, Anupam Sachdeva, Ishwar C. Verma & Pramod K. Mistry. (2018) Diagnosis and Management of Gaucher Disease in India – Consensus Guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics. Indian Pediatrics 55:2, pages 143-153.
Crossref
Crossref
Lulu Kang, Xia Zhan, Xuefan Gu & Huiwen Zhang. (2017) Successful newborn screening for Gaucher disease using fluorometric assay in China. Journal of Human Genetics 62:8, pages 763-768.
Crossref
Crossref
John Marshall, Ying Sun, Dinesh S Bangari, Eva Budman, Hyejung Park, Jennifer B Nietupski, Amy Allaire, Mary A Cromwell, Bing Wang, Gregory A Grabowski, John P Leonard & Seng H Cheng. (2016) CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease. Molecular Therapy 24:6, pages 1019-1029.
Crossref
Crossref
Alicja Markuszewska-Kuczyńska & Maciej Machaczka. (2015) Zarys objawów klinicznych, leczenia oraz trudności w rozpoznawaniu choroby Gauchera. Acta Haematologica Polonica 46:2, pages 149-157.
Crossref
Crossref
Timothy M. Cox. (2015) Innovative Treatments for Lysosomal Diseases. Best Practice & Research Clinical Endocrinology & Metabolism 29:2, pages 275-311.
Crossref
Crossref
Karin Weiss, Ashley N. Gonzalez, Grisel Lopez, Leah Pedoeim, Catherine Groden & Ellen Sidransky. (2015) The clinical management of type 2 Gaucher disease. Molecular Genetics and Metabolism 114:2, pages 110-122.
Crossref
Crossref
Carla E. M. Hollak & Frits A. Wijburg. (2014) Treatment of lysosomal storage disorders: successes and challenges. Journal of Inherited Metabolic Disease 37:4, pages 587-598.
Crossref
Crossref
Maciej Machaczka. (2013) Co hematolog powinien wiedzieć o chorobie Gauchera. Acta Haematologica Polonica 44:3, pages 301-306.
Crossref
Crossref